GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,498.00p
   
  • Change Today:
    -11.00p
  • 52 Week High: 1,671.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,095.71m
  • Volume: 5,675,856
  • Market Cap: £61,354m
  • RiskGrade: 129

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
2.46% below the market average2.46% below the market average2.46% below the market average2.46% below the market average2.46% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
1yr Revenue Growth
0.49% below the market average0.49% below the market average0.49% below the market average0.49% below the market average0.49% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
16.44% above the market average16.44% above the market average16.44% above the market average16.44% above the market average16.44% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
1yr DPS Growth
8.20% above the market average8.20% above the market average8.20% above the market average8.20% above the market average8.20% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
7.69% below the market average7.69% below the market average7.69% below the market average7.69% below the market average7.69% below the market average
61.54% below the sector average61.54% below the sector average61.54% below the sector average61.54% below the sector average61.54% below the sector average
Price Book Ratio
77.57% below the market average77.57% below the market average77.57% below the market average77.57% below the market average77.57% below the market average
28.21% below the sector average28.21% below the sector average28.21% below the sector average28.21% below the sector average28.21% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
53.66% above the market average53.66% above the market average53.66% above the market average53.66% above the market average53.66% above the market average
47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average
Price Chg 3m
36.03% below the market average36.03% below the market average36.03% below the market average36.03% below the market average36.03% below the market average
4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
63.86% above the market average63.86% above the market average63.86% above the market average63.86% above the market average63.86% above the market average
76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average
Momentum 20
92.31% above the market average92.31% above the market average92.31% above the market average92.31% above the market average92.31% above the market average
90.48% above the sector average90.48% above the sector average90.48% above the sector average90.48% above the sector average90.48% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
17.46% above the market average17.46% above the market average17.46% above the market average17.46% above the market average17.46% above the market average
68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average
ROCE
69.14% above the market average69.14% above the market average69.14% above the market average69.14% above the market average69.14% above the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
91.27% above the market average91.27% above the market average91.27% above the market average91.27% above the market average91.27% above the market average
91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average
Forecast EPS
79.15% above the market average79.15% above the market average79.15% above the market average79.15% above the market average79.15% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.83% above the market average97.83% above the market average97.83% above the market average97.83% above the market average97.83% above the market average
93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average
Operating Profit Loss
97.94% above the market average97.94% above the market average97.94% above the market average97.94% above the market average97.94% above the market average
95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.22% above the market average97.22% above the market average97.22% above the market average97.22% above the market average97.22% above the market average
95.45% above the sector average95.45% above the sector average95.45% above the sector average95.45% above the sector average95.45% above the sector average
Cash
96.84% above the market average96.84% above the market average96.84% above the market average96.84% above the market average96.84% above the market average
95.56% above the sector average95.56% above the sector average95.56% above the sector average95.56% above the sector average95.56% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
73.91% above the market average73.91% above the market average73.91% above the market average73.91% above the market average73.91% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Buys 1y
99.34% above the market average99.34% above the market average99.34% above the market average99.34% above the market average99.34% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
95.07% below the market average95.07% below the market average95.07% below the market average95.07% below the market average95.07% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Brokers Percent Neutral
82.87% above the market average82.87% above the market average82.87% above the market average82.87% above the market average82.87% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,498.00p
Change Today -11.00p
% Change -0.73 %
52 Week High 1,671.00
52 Week Low 1,264.00
Volume 5,675,856
Shares Issued 4,095.71m
Market Cap £61,354m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.49% below the market average55.49% below the market average55.49% below the market average55.49% below the market average55.49% below the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average
Price Trend
31.74% above the market average31.74% above the market average31.74% above the market average31.74% above the market average31.74% above the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average
Income
70.96% above the market average70.96% above the market average70.96% above the market average70.96% above the market average70.96% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
34.43% below the market average34.43% below the market average34.43% below the market average34.43% below the market average34.43% below the market average
41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 10-Jun-2025

Time Volume / Share Price
12:55 75 @ 1,498.00p
12:55 214 @ 1,498.00p
12:55 46 @ 1,498.00p
12:54 378 @ 1,497.88p
12:54 533 @ 1,498.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page